ArticleInternational journal of retina and vitreous2021
Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses.
Article in International journal of retina and vitreous, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 7 citations in OpenAlex.
- Recurrent rhegmatogenous retinal detachment: incidence, established and emerging risk factors, and clinical outcomes.BMC ophthalmology · 2026Article
- Post-vitrectomy Macular Edema: Shedding Light on Incidence and Risk Factors.Ophthalmology and therapy · 2026Review
- Nomogram-based prediction of postoperative proliferative vitreoretinopathy following scleral buckling surgery for rhegmatogenous retinal detachment.International journal of ophthalmology · 2026Article
- Efficacy and safety of fluocinolone acetonide intravitreal implant (0.2 µg/day) in patients with post-surgical inflammation associated with macular edema: a case series study.Journal of ophthalmic inflammation and infection · 2025Article
- Clinical and spectral-domain optical coherence tomography findings and changes in new-onset macular edema after silicone oil tamponade.BMC ophthalmology · 2025Article
- Outcomes of intravitreal dexamethasone implant (OzurdexInternational journal of retina and vitreous · 2025Article
- Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)-Refractory to Medical Therapy.Diagnostics (Basel, Switzerland) · 2025Article
- Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, Pathogenesis, Risk Factors and Treatment.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
- Factors affecting the development of cystoid macular edema following pars plana vitrectomy with silicone oil placement: a retrospective cohort study.International journal of retina and vitreous · 2024Article
- Macular oedema secondary to rhegmatogenous retinal detachment repair: risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant.Eye (London, England) · 2024Article
- Navigated yellow subthreshold micropulse laser for refractory cystoid macular edema following rhegmatogenous retinal detachment surgery.American journal of ophthalmology case reports · 2024Article
- Can the Location of the Iris Claw Lens Influence the Development and Timing of Pseudophakic Macular Edema?Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Macular edema after surgery to treat rhegmatogenous retinal detachment: 1-year follow-up, incidence, and associated risk factors.Arquivos brasileiros de oftalmologia · 2024Observational
- Risk Factors of Cystoid Macular Edema After Pars Plana Vitrectomy for Pseudophakic Retinal Detachment.Ophthalmology and therapy · 2023Article
- Postoperative complications after successful primary rhegmatogenous retinal detachment repair.BMC ophthalmology · 2023Observational
- Intravitreal Dexamethasone Implant at the Time of Silicon Oil Removal to Treat Persistent Macular Edema after Rhegmatogenous Retinal Detachment Repair.Journal of clinical medicine · 2023Article
- How should we report the foveal status in eyes with "macula-off" retinal detachment?Eye (London, England) · 2023Review
- Commentary: Treatment of postoperative cystoid macular edema in vitrectomized eyes: An enigma.Indian journal of ophthalmology · 2023Article
- Cystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes.Journal of clinical medicine · 2022Article
- Macular edema after pars plana vitrectomy for primary rhegmatogenous retinal detachment: Incidence, morphology, and risk factors.Oman journal of ophthalmologyArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors at 4 institutions in 4 countries.
Funding
Abstract
purposeTo investigate risk factors, imaging characteristics, and treatment responses of cystoid macular edema (CME) after rhegmatogenous retinal detachment (RRD) repair.
methodsConsecutive, retrospective case-control series of patients who underwent pars plana vitrectomy (PPV) and/or scleral buckling (SB) for RRD, with at least six months of follow-up. Clinical and surgical parameters of patients with and without CME (nCME), based on spectral-domain optical coherence tomography (OCT), were compared.
resultsOf 99 eyes enrolled, 25 had CME while 74 had nCME. Patients with CME underwent greater numbers of surgeries (P < 0.0001). After adjusting for number of surgeries, macula-off RRD (P = 0.06), proliferative vitreoretinopathy (PVR) (P = 0.09), surgical approach (PPV and/or SB, P = 0.21), and tamponade type (P = 0.10) were not statistically significant, although they all achieved significance on univariate analysis (P = 0.001 or less). Intraoperative retinectomy (P = 0.009) and postoperative pseudophakia or aphakia (P = 0.008) were more frequent in the CME group, even after adjustment. Characteristics of cCME on OCT included diffuse distribution, confluent cysts, and absence of subretinal fluid or intraretinal hyperreflective foci. Macular thickness improved significantly with intravitreal triamcinolone (P = 0.016), but not with anti-vascular endothelial growth factor agents (P = 0.828) or dexamethasone implant (P = 0.125). After adjusting for number of surgeries and macular detachment, final visual acuities remained significantly lower in the CME vs nCME group (P = 0.012).
conclusionRisk factors of CME include complex retinal detachment repairs requiring multiple surgeries, and pseudophakic or aphakic lens status. Although this cCME was associated with poor therapeutic response, corticosteroids were the most effective studied treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.